Phosphoaminophosphonic Acid-Adenylate Ester

DB04395ExperimentalSmall molecule

5'-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is... It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation.

Formula / weight: C₁₀H₁₇N₆O₁₂P₃ · 506.1963 g/mol (avg)

Resolves to

Compound

PubChem44462678

Structure

InChIKeyPVKSNHVPLWYQGJ-FCIPNVEPSA-NSMILESNC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O

Targets

P49841GSK3BP23919DTYMKQ56310cheAP08069IGF1RP11309PIM1P45510dhaKP0A6I3coaAP19367HK1+41 more

What you can answer from here — as of August 31, 2026

49Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

62+ReferencesStructured and connected to the statements they support

Which drugs share a target with Phosphoaminophosphonic Acid-Adenylate Ester, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account